Physician profile
Ian Suzelis
NPI 1124260435
$4,994.98
in general payments reported to CMS, 2019-2025
32 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $140 · 2021: $958 · 2022: $1,023 · 2023: $821 · 2024: $816 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,743.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,265.39 | 2020-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $928.56 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $446.39 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $426.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $369.65 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.68 | 2020-2024 | Tradjenta, Jardiance |
| Glaxosmithkline, LLC. | $158.36 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $147.02 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $122.34 | 2022-2024 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.79 | 2020-2024 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $88.04 | 2022 | |
| Amarin Pharma, INC. | $69.75 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.87 | 2019-2022 | |
| Astellas Pharma US INC | $61.26 | 2023-2024 | Veozah |
| Axsome Therapeutics, INC. | $53.85 | 2023 | Auvelity |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $49.98 | 2019-2020 | |
| Dexcom, INC. | $45.24 | 2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $44.25 | 2021 | |
| Electromed, INC. | $41.08 | 2025 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $40.34 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $38.13 | 2022 | |
| Ibsa Pharma INC. | $34.20 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $23.25 | 2019 | |
| Corium, LLC | $19.67 | 2023 | Adlarity |
| Clarus Therapeutics INC. | $18.63 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.81 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.75 | 2025 | Caplyta |
| Idorsia Pharmaceuticals US INC | $15.00 | 2023 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $14.85 | 2021 | |
| Acella Pharmaceuticals, LLC | $14.12 | 2025 | NP Thyroid 60 |
| E.R. Squibb & Sons, L.L.C. | $13.91 | 2024 | Camzyos |
| Merck Sharp & Dohme LLC | $13.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Suzelis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.